On June 28, 2016, Seegene received the South Korea In-Vitro Diagnostics Company of the Year Award at the 2016 Frost & Sullivan South Korea Excellence Awards, hosted by the global consulting company Frost & Sullivan. It was the second consecutive year in which the company received an award in the in-vitro diagnostics category.

The Frost & Sullivan South Korea Excellence Awards recognizes companies working in various industries in the global market for their outstanding accomplishments in technological innovation, customer service, and strategic development. Seegene was selected as an award winner this year for its outstanding evaluation scores in In-Vitro Diagnostics field, including its innovative products using their unique Multiplex Molecular Diagnostics(MDx) technologies (DPO^TM, TOCE^TM and MuDT^TM), success in entering the global market, and development of software that strengthened its customer service.

A Seegene spokesperson said, “By enhancing our product development capabilities and expanding our portfolio of molecular diagnostic products which can be applied in a single diagnostic platform based on Seegene’s multiplex MDx technologies, Seegene will maintain its leadership in molecular diagnostics.”

?

Frost & Sullivan International

As a “partner for growth,” Frost & Sullivan cooperates with it clients to help them achieve accelerated growth. Through various programs, including its TEAM Research and Growth Consulting and Growth Team Membership programs, the organization helps its clients establish a growth-oriented culture through the development, implementation, and evaluation of effective growth strategies. With over 50 years of experience in its field, Frost & Sullivan currently has over 40 offices on six continents and works together with over 1,000 global companies in the investment sector and various new business areas.

Source: Frost & Sullivan International